Skip to Content

T. Rowe Price International Eq Index PIEQX

Medalist Rating as of | See T. Rowe Price Investment Hub
  • NAV / 1-Day Return 16.69  /  +1.15 %
  • Total Assets 744.5 Mil
  • Adj. Expense Ratio
    0.260%
  • Expense Ratio 0.260%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 2,500
  • Status Open
  • TTM Yield 2.85%
  • Turnover 29%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:16 PM GMT+0

Morningstar’s Analysis PIEQX

Will PIEQX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin T. Rowe Price International Eq Index's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the least expensive fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings PIEQX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 16.1
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.83 27.6 Mil
Healthcare

ASML Holding NV

2.48 24.1 Mil
Technology

Nestle SA

1.64 15.9 Mil
Consumer Defensive

AstraZeneca PLC

1.45 14.1 Mil
Healthcare

Shell PLC

1.39 13.5 Mil
Energy

Toyota Motor Corp

1.31 12.7 Mil
Consumer Cyclical

SAP SE

1.27 12.4 Mil
Technology

Lvmh Moet Hennessy Louis Vuitton SE

1.27 12.3 Mil
Consumer Cyclical

Novartis AG Registered Shares

1.26 12.3 Mil
Healthcare

Msci Eafe Fut 9/24

1.24 12.1 Mil